$87.3 Million is the total value of University of Wisconsin Foundation's 5 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 150.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IVV | Sell | ISHARES TRcore s&p500 et | $60,355,528 | -50.1% | 140,548 | -48.2% | 69.16% | -22.2% |
| NU HLDGS LTD | $13,842,186 | -8.1% | 1,909,267 | 0.0% | 15.86% | +43.1% | ||
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $5,861,023 | – | 40,133 | +100.0% | 6.72% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $5,251,013 | – | 103,816 | +100.0% | 6.02% | – |
| ETNB | New | 89BIO INC | $1,953,407 | – | 126,516 | +100.0% | 2.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 3 | Q3 2023 | 88.9% |
| NU HLDGS LTD | 3 | Q3 2023 | 17.3% |
| ISHARES TR | 1 | Q4 2022 | 83.9% |
| NU HLDGS LTD | 1 | Q4 2022 | 16.1% |
| MADRIGAL PHARMACEUTICALS INC | 1 | Q3 2023 | 6.7% |
| AKERO THERAPEUTICS INC | 1 | Q3 2023 | 6.0% |
| 89BIO INC | 1 | Q3 2023 | 2.2% |
| HEADHUNTER GROUP PLC | 1 | Q1 2023 | 0.3% |
View University of Wisconsin Foundation's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
View University of Wisconsin Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.